Thrombopoietin Receptor Agonist Market End User Analysis: Hospitals Leading Demand
The Thrombopoietin Receptor Agonist Market derives substantial revenue from its hospitals end-user segment, which remains a critical channel for TPO-RA administration and management. Hospitals serve as the primary setting for initial TPO-RA therapy, particularly for acute thrombocytopenia management, perioperative platelet optimization, and complex cases requiring multidisciplinary hematology...
0 Commentarii 0 Distribuiri 12 Views 0 previzualizare